⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

BridgeBio Oncology Therapeutics, Inc. Common Stock

$2.64
+0.08 (+3.13%)

Volume:

2.791K ($7.37K)

Market Capitalization:

$211.66M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

BridgeBio Oncology Therapeutics Market Segments

Premarket

+0.12(+4.76%)
Open$2.52
Close$2.64
Low$2.52
Low Change0.00 (0.00%)
High$2.67
High Change+0.15 (+5.95%)
Range$0.15
Volume2.791K
Dollar Volume$7.37K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.03(-1.17%)
Open$2.56
Close$2.53
Low$2.50
Low Change-0.06 (-2.34%)
High$2.57
High Change+0.01 (+0.39%)
Range$0.07
Volume88.416K
Dollar Volume$223.69K

Regular Trading Hours Yesterday

+0.23(+9.87%)
Open$2.33
Close$2.56
Low$2.25
Low Change-0.08 (-3.43%)
High$2.65
High Change+0.32 (+13.73%)
Range$0.40
Volume1.324M
Dollar Volume$3.39M

Premarket Yesterday

*No Trades in Segment

BridgeBio Oncology Therapeutics Top Trades

BridgeBio Oncology Therapeutics's top trade so far today returned +5.95%, while the top short trade returned -1.12%.

BridgeBio Oncology Therapeutics Moving Averages

5 Day Moving Average (SMA5)$2.26
10 Day Moving Average (SMA10)$2.35
20 Day Moving Average (SMA20)$2.56
50 Day Moving Average (SMA50)$3.91
100 Day Moving Average (SMA100)$6.28
200 Day Moving Average (SMA200)$7.74

BridgeBio Oncology Therapeutics Statistics

Average Volume (30 Days)620.65K
P/E Ratio (Current)-.97
EPS (Current)-$2.27
Dividend Yield0.00%
Free Cash Flow-$193.82M
Cash Ratio1.05
Current Ratio4.69
Quick Ratio4.69
Debt to Equity0.00
Enterprise Value$122.32M
EV to EBITDA-0.62
EV to Sales—
Price to Book0.55
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.48%
Return on Equity-0.56%

BridgeBio Oncology Therapeutics Stock Splits

There have been no stock splits for BridgeBio Oncology Therapeutics (BBOT).

BridgeBio Oncology Therapeutics Dividends

There have been no dividends for BridgeBio Oncology Therapeutics (BBOT).